When you take a GLP-1 medication, you may feel full quicker, get bloated, or feel nauseous if you try to eat the way you did prior to starting the medication, says Raghuveer Vedala, MD, an assistant professor at the University of Oklahoma College of Medicine in Oklahoma City
BPC-157 is currently highly experimental in humans
Cardiometabolic Burden in Serious Mental Illness Schizophrenia, major depressive disorder, bipolar disorder (BD), and other SMIs are severe, prevalent, and lifelong conditions that are major contributors to disability, reduced healthspan, and diminished social and economic participation, particularly in younger populations
Until now there are only a few available targeted therapies for MM clinical trials: BRAF, MEK, CDK4/6 and, C-KIT inhibitors, with limited clinical use and efficacy